Stay updated on Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.

Latest updates to the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; this is a routine site maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRemoved the government funding lapse warning; study details and enrollment information remain the same with no new trial information added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedNo substantial additions or deletions were detected; the study details page content remains unchanged aside from minor formatting adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference2%

- Check70 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2, indicating a minor patch; no substantive changes to core content or critical data. A Back to Top link was removed as a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj TIL & Pembrolizumab in Adv Melanoma Clinical Trial page.